Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue

被引:87
作者
Yanagida, C
Ito, K
Komiya, I
Horie, T
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Chiba 2608675, Japan
[2] Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Yokohama, Kanagawa 2228567, Japan
关键词
fosfomycin; gentamicin; lipid peroxidation; mitochondria; nephrotoxicity;
D O I
10.1016/j.cbi.2004.05.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fosfomycin is clinically recognized to reduce the aminoglycoside antibiotics-induced nephrotoxicity. However, little has been clarified why fosfomycin protects the kidney from the aminoglycosides-induced nephrotoxicity. Gentamicin, a typical aminoglycoside, is reported to cause lipid peroxidation. We focused on lipid peroxidation induced by gentamicin as a mechanism for the aminoglycosides-induced nephrotoxicity. The aim of this study is to investigate the effect of fosfomycin on the gentamicin-induced lipid peroxidation. In rat renal cortex mitochondria, fosfomycin was shown to depress the gentamicin-induced lipid peroxidation, which was evaluated by formation of thiobarbituric acid reactive substances (TBARS). Interestingly, this effect was observed in rat renal cortex mitochondria, but not in rat liver microsomes. However, fosfomycin did not affect lipid peroxidation of arachidonic acid caused by gentamicin with iron. Fosfomycin inhibited the gentamicin-induced iron release from rat renal cortex mitochondria. These results indicated that fosfomycin inhibited the gentamicin-induced lipid peroxidation by depressing the iron release from mitochondria. This may possibly be one mechanism for the protection of fosfomycin against the gentamicin-induced nephrotoxicity. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 33 条
  • [1] Protective effects of vitamin E and probucol against gentamicin-induced nephrotoxicity in rats
    Abdel-Naim, AB
    Abdel-Wahab, MH
    Attia, FF
    [J]. PHARMACOLOGICAL RESEARCH, 1999, 40 (02) : 183 - 187
  • [2] Mitochondrial Dysfunction in Neurodegenerative Diseases
    Johri, Ashu
    Beal, M. Flint
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) : 619 - 630
  • [3] BENISMAIL TH, 1994, GEN PHARMACOL, V25, P1249
  • [4] RELEASE OF IRON FROM FERRITIN BY XANTHINE-OXIDASE - ROLE OF THE SUPEROXIDE RADICAL
    BOLANN, BJ
    ULVIK, RJ
    [J]. BIOCHEMICAL JOURNAL, 1987, 243 (01) : 55 - 59
  • [5] Buege J A, 1978, Methods Enzymol, V52, P302
  • [6] INVIVO GENERATION OF HYDROGEN-PEROXIDE BY RAT-KIDNEY CORTEX AND GLOMERULI
    GUIDET, BR
    SHAH, SV
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (01): : F158 - F164
  • [7] INOUYE S, 1982, J PHARMACOBIO-DYNAM, V5, P659
  • [8] INOUYE S, 1982, J PHARMACOBIO-DYNAM, V5, P941
  • [9] Johnson D., 1967, Meth Enzymol, V10, P94, DOI [10.1016/0076-6879(67)10018-9, DOI 10.1016/0076-6879(67)10018-9]
  • [10] IRON SUPPLEMENTATION INCREASES GENTAMICIN-NEPHROTOXICITY IN RATS
    KAYS, SE
    CROWELL, WA
    JOHNSON, MA
    [J]. JOURNAL OF NUTRITION, 1991, 121 (11) : 1869 - 1875